Allograft Tissue
Payments companies reported to CMS as associated with Allograft Tissue. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Allograft Tissue, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Allograft Tissue
These are the largest totals companies reported as associated with Allograft Tissue. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Gary Lepow | Houston, TX | Podiatrist | $17,101.51 |
| Nathan Skelley | Sioux Falls, SD | Orthopaedic Surgery | $13,341.89 |
| David Flanigan | Columbus, OH | Sports Medicine (Orthopaedic Surgery) | $11,874.11 |
| David Welker | Miamisburg, OH | Orthopaedic Surgery | $9,963.10 |
| Scott Carrington | La Crosse, WI | Podiatrist | $9,632.41 |
| Kevin Martin | Gahanna, OH | Orthopaedic Surgery | $9,307.69 |
| Raymond Walls | New York, NY | Foot and Ankle Surgery | $9,160.58 |
| Amit Momaya | Birmingham, AL | Sports Medicine (Orthopaedic Surgery) | $9,141.36 |
| Drew Lansdown | San Francisco, CA | Orthopaedic Surgery | $8,906.16 |
| John Kosko | Hattiesburg, MS | Foot and Ankle Surgery | $7,313.92 |
Prescribed Allograft Tissue?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.